Topical application of honey in the management of radiation mucositis. A preliminary study

Supportive Care in Cancer

Volumn 11, Issue 4, 2003, Pages 242-248

  Biswal, Biswa Mohan ^a   Zakaria, Ahmad ^a   Ahmad, Nik Min ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Acute morbidity; Honey; Radiation mucositis; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HONEY; HUMAN; LINEAR ACCELERATOR; MALE; MUCOSA INFLAMMATION; OROPHARYNX; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; WEIGHT GAIN;

EID: 0038343556     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0443-y     Document Type: Article

References (41)

1. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50:7-33
2. Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncl Biol Phys 47:1-12
3. Lee DJ, Cosmatos D, Marcial VA et al (1995) Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys 32:567-576
4. Fu KK (1993) RTOG (90-03): A phase III randomized study to compare twice daily hyperfractionation, accelerated fractionation with concomitant boost to standard fractionation radiotherapy for squamous cell carcinoma of the head and neck. Data on file, Radiation Treatment Oncology Group, Philadelphia
5. Horiot K, Le Fur R, N'Guyen T et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231-241
6. Dische S, Saunders M, Barrett A et al (1997) Accelerated fractionation (AF) compared to conventional fractionation (CF) Improve loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 trial. Radiother Oncol 44:123-136
7. Trotti A, Mocharnuk RS (2001) Management of radiation-induced toxicity in patients with head and neck cancer. Medscape 6:1-14
8. Epstein JB, Wong FL (1994) The efficacy of sucralfate suspension in the prevention of mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys 28:693-698
9. DeVries A, Sprinzl G, Reich K, Gunczler P, Thumfart W, Lukas P (2001) GM-CSF-mouth wash for treatment of chemotherapy patients with advanced head and neck cancer: A clinical trial. Annals Oncol 11 [Suppl 4]:409PD
10. Throuvales N, Antonadou D, Pullizi M et al (1997) Evaluation of efficacy and safety of GM-CSF in the prophylaxis of mucositis in patients with head and neck cancer patients treated radiation therapy. Eur J Cancer 41A [Suppl 7]:431
11. Hanson WR, Marks JE, Reddy SP, et al (1997). Protection from radiation induced oral mucositis by a mouth rinse containing prostaglandin E analogue, misoprostol: a placebo controlled. Double blind clinical trial. Adv Exp Med Biol 400B:811-818
12. Leborgne JH, Leborgne F, Zubizarreta E, Ortega B, Mezzera J (1997) Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomised trial. Radiother Oncol 47:145-148
13. Tannehill SP, Mehta MP (1996) Amifostine and radiation therapy: past, present and future. Semin Oncol 23 [Suppl 8]:69-77
14. Moore OA, Smith LA, Campbell F, Seers Kate, McQuay, Moore RA (2001) Systematic review of the use of honey as a wound dressing. BMC Compliment Altern Med 1(1):2
15. Ovington LG. Honey (1999) Ancient cure or modern alternative? Wound Care Institute Newsletter, vol 4/1, January/February, Altanta
16. Vardi A, Barzilay Z, Linder N, Cohen HA, Paret G, Brazilai A (1998) Local application of honey for the treatment of neonatal postoperative wound infection. Acta Paediatrica 87:429-432
17. Efem SEE, Udoh KT, Iwara CI (1992) The antimicrobial spectrum of honey and its clinical significance. Infection 20:227-229
18. Sela M, Maroz D, Gedalia I (2000) Streptococcus mutant in saliva of normal subjects and neck and head irradiated cancer subjects after consumption of honey. J Oral Rehab 27:269-270
19. Al-Waili NS, Saloom KY (1999) Effect of topical honey on postoperative wound infections due to gram positive and gram negative bacteria following caesarean section and hysterectomies. Eur J Med Res 26:126-130
20. Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS (1995) Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res 55:2310-2315
21. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
22. Rahn R, Adamietz IA, Boettcher et al (1997) Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 195 [Suppl 2]:57-61
23. Al-Tikriti U, Martin MV, Bramley PA (1984) A pilot study of the clinical effects of irradiation on the oral tissues. Br J Oral Maxillofac Surg 22:77-86
24. Bernhoft CH, Skaug N (1985) Oral findings in irradiated edentulous patients. Int J Oral Surg 14:416
25. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:1-12
26. Machteld Wymenga AN, Van der Graaf WTA, Hofstra LS et al (1999) Phase I study of Transforming growth factor β3 mouthwash for prevention of chemotherapy induced mucositis. Clin Cancer Res 5:1363-1368
27. Dorr W, Noack R, Spekl K, Forrell CL (2001) Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol 77:341-347
28. Schuchter LM, Luginbuhl WE, Meropol NH (1992) The current status of toxicity protectants in cancer therapy. Semin Oncol 19:742-751
29. Schonekas KG, Wagner W, Prott FJ (1999) Amifostine a radioprotector in locally advanced head and neck tumors. Strahlenther Onkol 175 [Suppl 4]:30-33
30. Perch SJ, Machtay M, Markiewicz DA, Kligerman MM (1995) Decreased acute toxicity by using midline mucosal sparing block during radiation therapy for carcinoma of the oral cavity, oropharynx and nasopharynx. Radiology 197:863-866
31. Bensadoun RJ, Franquin JC, Ciais G et al (1999) Low energy He/Ni laser in the prevention of radiation mucositis: A multicenter phase III randomised study in patients with head and neck cancer. Support Care Cancer 7:217-218
32. Petrovic ZT, Mandic ML, Grgic J, Grgic Z (1994) Ash and chromium levels of some type of honey. Z Lebensm Unters Forsch 198:36-39
33. Qiu PY, Ding HB, Tang YK, Xu RJ (1999) Determination of chemical composition of commercial honey by near-infrared spectroscopy. J Agric Food Chem 47:2760-2765
34. Liza G, Ovington CWS (1999) Honey: Ancient cure or modern alternative. Wound Care Institute News Letter 4:1-3
35. Bergman A, Yanai J, Weiss J, Bell D, Menachem PD (1983) Acceleration of wound healing by topical application of honey. An animal model. Am J Surg 145:374-376
36. Oryan A, Zaker SR (1998) Effect of topical application of honey on cutaneous wound healing in rabbits. Zentralbl Veterinarmed A 45:181-188
37. Molan PC (1999) The role of honey in the management of wound. J Wound Care 8:423-426
38. Archer HG, Bernett S, Irving S, Middleton KR, Seal DV (1990) A controlled model of moist wound healing: comparison between semi-permeable film antiseptic and sugar paste. J Exp Pathol 71:155-170
39. Knutson RA, Merbitz LA, Creekmore MA, Snipes HG (1981) Use of sugar and povidone iodine to enhance the wound healing: five year's experience. South Med J 74:1329-1335
40. Sela MO, Shapira L, Grizim I, et al (1998) Effects of honey consumption on enamel microhardness in normal versus xerostomic patients. J Oral Rehabil 25:630-634
41. Smirnova H, Filatova EI, Suvorov AN, Bylinskaia EN (2002) The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumours. Vopr OnKol 46:748-750